ID25978A - Antibodi anti-fas - Google Patents

Antibodi anti-fas

Info

Publication number
ID25978A
ID25978A IDP990903D ID990903D ID25978A ID 25978 A ID25978 A ID 25978A ID P990903 D IDP990903 D ID P990903D ID 990903 D ID990903 D ID 990903D ID 25978 A ID25978 A ID 25978A
Authority
ID
Indonesia
Prior art keywords
fas
fas antibody
abnormalities
mouse
reactive
Prior art date
Application number
IDP990903D
Other languages
English (en)
Indonesian (id)
Inventor
Nobufusa Serizawa
Hidiyukiharuyama
Kaori Nakahara
Ikuko Tamaki
Tohru Takashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ID25978A publication Critical patent/ID25978A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP990903D 1998-09-30 1999-09-29 Antibodi anti-fas ID25978A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27688298 1998-09-30
JP27688198 1998-09-30

Publications (1)

Publication Number Publication Date
ID25978A true ID25978A (id) 2000-11-16

Family

ID=26552152

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990903D ID25978A (id) 1998-09-30 1999-09-29 Antibodi anti-fas

Country Status (14)

Country Link
EP (1) EP0990663A3 (de)
KR (1) KR20000023549A (de)
CN (1) CN1266714A (de)
AR (1) AR023333A1 (de)
AU (1) AU757961B2 (de)
BR (1) BR9904475A (de)
CA (1) CA2283540A1 (de)
HU (1) HUP9903299A3 (de)
ID (1) ID25978A (de)
IL (1) IL132139A0 (de)
NO (1) NO994750L (de)
NZ (1) NZ500019A (de)
PL (1) PL335752A1 (de)
RU (1) RU2223115C2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087993B1 (de) 1998-06-18 2008-04-02 Imed Ab Fas peptide und antikörper zur modulierung von apoptosis
CN1642981A (zh) 2002-03-25 2005-07-20 独立行政法人科学技术振兴机构 识别增殖性人肝细胞的抗体、增殖性人肝细胞和功能性人肝细胞
NZ550816A (en) * 2004-04-22 2009-12-24 Agensys Inc Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
CA2572098C (en) * 2004-06-30 2015-01-27 Mayo Foundation For Medical Education And Research B7-dc binding antibody
CN103351435B (zh) * 2006-06-06 2015-08-19 克鲁塞尔荷兰公司 具有杀灭葡萄球菌活性的人结合分子及其应用
JP2010512315A (ja) * 2006-12-06 2010-04-22 メディミューン，エルエルシー インターフェロンα誘導性薬力学的マーカー
AU2008342942A1 (en) * 2007-12-28 2009-07-09 Biolnvent International Ab Formulation
US9309312B2 (en) * 2008-10-31 2016-04-12 Toray Industries, Inc. Immunoassay method for human CXCL1 protein
DK2186829T3 (en) * 2008-11-14 2015-04-07 Canadian Blood Services Antibodies to GPIbalfa
RU2519196C2 (ru) * 2011-07-01 2014-06-10 Олег Ильич Эпштейн Лекарственное средство для лечения патологического синдрома и способ лечения рассеянного склероза
TWI595007B (zh) 2012-09-10 2017-08-11 Neotope Biosciences Ltd 抗ｍｃａｍ抗體及相關使用方法
KR20160127825A (ko) 2014-03-12 2016-11-04 프로테나 바이오사이언시즈 리미티드 항-mcam 항체 및 관련된 사용 방법
CA2938931A1 (en) * 2014-03-12 2015-09-17 Prothena Biosciences Limited Anti-laminin4 antibodies specific for lg1-3
JP2017514458A (ja) 2014-03-12 2017-06-08 プロセナ バイオサイエンシーズ リミテッド Ｌｇ４−５に対して特異的な抗−ラミニン４抗体
CN116059316A (zh) * 2015-10-23 2023-05-05 优瑞科生物技术公司 抗体/t细胞受体嵌合构建体及其用途
CN114507284B (zh) * 2020-05-09 2023-05-26 华博生物医药技术（上海）有限公司 抗tigit的抗体、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA982371B (en) * 1997-03-21 1998-09-28 Sankyo Co Humanized anti-human fas antibody
AU734758B2 (en) * 1997-04-01 2001-06-21 Sankyo Company Limited Anti-fas antibodies

Also Published As

Publication number Publication date
NO994750L (no) 2000-03-31
EP0990663A3 (de) 2002-04-17
AR023333A1 (es) 2002-09-04
HUP9903299A3 (en) 2004-05-28
EP0990663A2 (de) 2000-04-05
NZ500019A (en) 2001-06-29
AU757961B2 (en) 2003-03-13
HUP9903299A2 (hu) 2000-11-28
PL335752A1 (en) 2000-04-10
RU2223115C2 (ru) 2004-02-10
AU5016199A (en) 2000-04-13
HU9903299D0 (en) 1999-11-29
BR9904475A (pt) 2000-12-12
NO994750D0 (no) 1999-09-29
CN1266714A (zh) 2000-09-20
CA2283540A1 (en) 2000-03-30
KR20000023549A (ko) 2000-04-25
IL132139A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
NO994750D0 (no) Anti-Fas-antistoffer
FI901344A0 (fi) Monoklonala antikroppar reaktiva med tnf.
ATE437655T1 (de) Humanisierte anti-erbb2 antikörper und behandlung mit anti-erbb2 antikörper
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
DE69128543D1 (de) Monoklonale antikörper der maus
DE69129743D1 (de) Humanisierte chimäre anti-"icam-1" antikörper, herstellungsverfahren und verwendung
DE3854194D1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
NO20001104D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende slike samt terapeutiske anvendelser derav
DE69126664D1 (de) Bestimmung von analyten in biologischen flüssigkeiten in gegenwart von störenden substanzen
FI961083L (fi) Rekombinentti-IL4-vasta-aineita, jotka ovat käyttökelpoisia IL-4-välitteisten häiriötilojen hoidossa
ID20117A (id) Antibodi anti-fas
FR2631239B1 (fr) Anticorps monoclonal humain et hybridome le produisant
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
ID20065A (id) Antibodi fas anti-manusia yang disesuaikan untuk manusia
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
DE69529744D1 (de) Monoklonale antikörper spezifisch gegen vaskuläres endothelzellartigen endoglyx-1, das antigen selbst und seine verwendungen
FR2773157B1 (fr) Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
ATE189897T1 (de) Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet
FI971879L (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
TR199902410A2 (xx) Anti-Fas Antikorları
RU98104739A (ru) Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией
IT1301815B1 (it) Anticorpi monoclonali umani contro l'antigene tumorale uk114 e cellulelinfocitarie e ibridomi per la loro produzione
ATE99332T1 (de) Monoklonale antikoerper gegen menschliche interleukin-4 und die sie erzeugenden hybridomen.
Magleby et al. Controlling agricultural runoff: Government's perspective.